Stent Grafts Sales Market Outlook

The global stent grafts market is projected to reach USD 5.1 billion by 2035, growing at a CAGR of approximately 8.6% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of vascular diseases, advancements in stent graft technology, and a growing aging population that is more susceptible to conditions requiring stent placement. Additionally, the rising awareness regarding minimally invasive surgical procedures and the improvements in healthcare infrastructure across developing regions are contributing to the market's expansion. As a result, the market dynamics are evolving, with innovations and an increasing portfolio of stent graft options available for various medical applications.

Growth Factor of the Market

Several factors are converging to drive the growth of the stent grafts market. Firstly, the rising incidence of cardiovascular diseases, particularly aortic aneurysms and peripheral artery disease, is significantly increasing the demand for stent grafts as effective treatment options. Secondly, technological innovations, such as drug-eluting stent grafts and bioabsorbable materials, are enhancing the performance and functionality of stents, thereby attracting healthcare providers to adopt newer solutions. Thirdly, the emphasis on minimally invasive surgical techniques is making stent grafts a preferred choice for many surgeons due to reduced recovery times and lower complication rates compared to traditional open surgeries. Furthermore, the expanding healthcare expenditure in emerging economies is facilitating access to advanced medical devices, thereby widening the market scope. Lastly, ongoing research and development efforts are likely to yield novel products that can cater to a broader range of vascular issues.

Key Highlights of the Market

• The stent grafts market is anticipated to witness robust growth due to increasing prevalence of vascular diseases.
• Technological advancements in stent graft design and materials are enhancing treatment outcomes.
• Minimally invasive procedures are becoming the standard of care, favoring stent graft adoption.
• Emerging economies are experiencing increased healthcare investments, expanding market access.
• Research and innovation are expected to bring forth new products, increasing market diversity.

By Product Type

Branched Stent Grafts:

Branched stent grafts are specialized devices designed to treat complex aortic aneurysms while preserving blood flow to vital arteries. They feature branched designs that allow for the inclusion of side branches, ensuring that blood supply to the renal and visceral arteries is maintained during the repair. The versatility of branched stent grafts makes them particularly valuable in cases where traditional stent grafts would not suffice. This product type is gaining traction in the market due to its ability to effectively manage challenging vascular anatomies and improve patient outcomes, reflecting a broader trend towards customization in medical devices.

Fenestrated Stent Grafts:

Fenestrated stent grafts are another critical segment of the stent grafts market, specifically created to treat abdominal aortic aneurysms. These devices have openings or "fenestrations" that allow for blood flow through the branches of the aorta while still providing structural support to the vessel walls. This innovative design minimizes the risks associated with traditional grafting methods by reducing the need for open surgeries and hospital stays. The rising incidence of aortic aneurysms is driving the demand for fenestrated stent grafts as healthcare professionals look for effective solutions to complex cases that require meticulous attention to vascular integrity.

Thoracic Stent Grafts:

Thoracic stent grafts are utilized primarily for the treatment of thoracic aortic aneurysms and dissections. These stent grafts are designed to withstand the high pressures found in the thoracic region, providing a durable solution to patients suffering from severe vascular conditions. The increasing prevalence of thoracic aortic diseases, coupled with advancements in stent graft technology that improve delivery and deployment mechanisms, is expected to boost this segment's growth significantly. Moreover, the integration of imaging technologies facilitates improved surgical precision and enhances patient safety, further reinforcing the appeal of thoracic stent grafts in clinical settings.

Abdominal Stent Grafts:

Abdominal stent grafts focus on managing abdominal aortic aneurysms, one of the most common vascular conditions. These devices are designed to provide structural support to the aorta, preventing rupture and ensuring safe blood flow. The abdominal stent graft segment is witnessing substantial growth due to the increasing number of diagnoses of abdominal aortic aneurysms and the growing preference for endovascular approaches over traditional surgical methods. With the technological advancements in graft materials and designs, abdominal stent grafts are evolving to offer enhanced safety and efficacy, making them a popular choice among vascular surgeons.

Endovascular Aneurysm Repair Stent Grafts:

Endovascular aneurysm repair (EVAR) stent grafts are specifically designed for treating aortic aneurysms through minimally invasive techniques. The main advantage of EVAR stent grafts is their ability to reduce surgical trauma and recovery time compared to open surgical repairs. As a result, these devices are becoming increasingly popular in clinical practice. The growing patient population requiring vascular interventions and the continuous development of advanced EVAR devices are expected to drive the segment's growth significantly. Additionally, increasing awareness among healthcare practitioners regarding the benefits of this technology will likely facilitate further adoption in various healthcare settings.

By Application

Peripheral Artery Disease:

Peripheral artery disease (PAD) represents a significant application area for stent grafts, as it affects millions of individuals worldwide. PAD occurs when narrowed arteries reduce blood flow to the limbs, leading to severe complications if left untreated. Stent grafts provide an effective solution for restoring blood flow and alleviating symptoms associated with this condition. The increasing prevalence of risk factors such as diabetes, obesity, and a sedentary lifestyle is driving the demand for stent grafts in PAD treatment. Moreover, advancements in stent designs are enhancing treatment outcomes, leading to a higher adoption rate among healthcare providers.

Aortic Aneurysm:

Aortic aneurysms are among the critical conditions treated with stent grafts, as they can lead to life-threatening complications if not addressed promptly. The use of stent grafts in aortic aneurysm repair has revolutionized the management of this condition, offering patients reduced recovery times and lower surgical risks. The growing number of aortic aneurysm cases, coupled with the aging population, is substantially driving the demand for stent grafts in this application area. Additionally, increasing awareness of the benefits of endovascular techniques is contributing to the robust growth in this segment.

Renal Artery Stenosis:

Renal artery stenosis, characterized by the narrowing of the arteries supplying the kidneys, is another significant application of stent grafts. The condition can lead to hypertension and kidney damage if untreated. Stent grafts help restore blood flow to the kidneys, effectively managing renal artery stenosis. The increasing prevalence of hypertension and chronic kidney diseases is expected to boost the demand for stent grafts in this application area. Furthermore, advancements in imaging technologies and stent designs are allowing for improved patient outcomes, making stent grafts a preferred treatment option.

Other Cardiovascular Diseases:

Beyond specific applications such as PAD, aortic aneurysms, and renal artery stenosis, stent grafts are also deployed in treating various other cardiovascular diseases. This broad application spectrum reflects the versatility of stent graft technology, which is continually evolving to address diverse vascular challenges. As healthcare providers increasingly recognize the efficacy of stent grafts in managing complex vascular conditions, the demand for these devices is expected to rise. The ongoing innovation within the field and increased research efforts are likely to yield new applications, further expanding the market landscape.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for stent grafts, accounting for a significant share of the market. The centralized nature of hospitals allows for the procurement of advanced medical devices, ensuring that patients have access to the latest stent graft technologies. Moreover, hospitals are equipped with the necessary resources and facilities to perform complex procedures requiring stent grafts. The ongoing investments in hospital infrastructure and technology are expected to drive the growth of this segment, with the continuous influx of patients seeking treatment for vascular diseases contributing to increased demand.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are gaining traction as alternative distribution channels for stent grafts due to their cost-effectiveness and focus on outpatient procedures. ASCs offer the advantage of shorter waiting times and reduced costs for patients, making them an attractive option for both healthcare providers and patients. As the healthcare industry shifts towards value-based care models, the convenience and efficiency of ASCs are likely to propel their growth in the stent grafts market. Furthermore, the increasing number of procedures performed in ASCs is enhancing their role in the overall distribution landscape.

Specialty Clinics:

Specialty clinics focusing on vascular diseases are emerging as significant players in the stent grafts distribution channel. These clinics provide targeted care for patients with specific vascular conditions, ensuring personalized treatment plans and improved patient outcomes. The growing recognition of the benefits associated with specialized care is driving the demand for stent grafts within this segment. Additionally, the increasing number of specialty clinics being established in various regions is anticipated to enhance the accessibility of advanced vascular treatments, further bolstering the stent grafts market.

Online Sales:

Online sales channels are becoming increasingly relevant in the stent grafts market, as the digital transformation of healthcare continues to unfold. The convenience of online ordering and the ability to access a wide range of products have made this distribution channel appealing to healthcare providers and patients. Online platforms enable quicker procurement processes, allowing for timely access to necessary medical devices. As telehealth and digital healthcare services expand, the significance of online sales in the stent grafts market is expected to grow, diversifying the overall distribution landscape.

By Material Type

Polyester:

Polyester is one of the most widely used materials in the production of stent grafts due to its favorable properties such as durability, flexibility, and biocompatibility. This synthetic material provides excellent structural support and is commonly utilized in various types of stent grafts, particularly for vascular applications. The continued advancements in polyester technology are enhancing its performance characteristics, leading to its increasing adoption by healthcare providers. Moreover, the cost-effectiveness of polyester stent grafts contributes to their popularity in clinical settings, driving growth in this material segment.

ePTFE:

Expanded polytetrafluoroethylene (ePTFE) is another significant material used in stent graft manufacturing, known for its high biocompatibility and resistance to thrombosis. ePTFE stent grafts are particularly valued for their ability to facilitate smooth blood flow and minimize complications associated with graft application. The growing body of evidence supporting the efficacy of ePTFE stent grafts is likely to bolster their market presence, especially as healthcare providers increasingly prioritize patient safety. Furthermore, the development of advanced ePTFE technologies is expected to enhance the performance and longevity of stent grafts, contributing to their widespread acceptance.

PTFE:

Polytetrafluoroethylene (PTFE) stent grafts are renowned for their unique properties, including low friction and excellent chemical resistance, making them a viable option for vascular applications. The inert nature of PTFE minimizes the risk of adverse reactions in patients, enhancing its appeal as a material choice for stent grafts. As more research highlights the long-term benefits of PTFE stent grafts, their adoption rate among healthcare professionals is likely to rise. Additionally, ongoing advancements in PTFE technology are further improving the design and functionality of stent grafts, propelling growth in this material segment.

Nitinol:

Nitinol, a nickel-titanium alloy, is emerging as a valuable material in the stent grafts market due to its unique superelastic properties and ability to recover its shape after deformation. Nitinol stents provide excellent radial strength while maintaining flexibility, making them suitable for various vascular applications. The growing preference for nitinol stent grafts stems from their enhanced performance characteristics and reduced complications compared to traditional materials. Continuous research and development efforts aimed at optimizing nitinol technologies are expected to solidify their position in the stent grafts market, driving further innovation and adoption.

By Region

The stent grafts market exhibits significant regional variations, driven by factors such as the prevalence of vascular diseases, healthcare infrastructure, and regulatory frameworks. North America remains the largest market for stent grafts, accounting for approximately 45% of the global market share in 2025. This dominance can be attributed to the high prevalence of cardiovascular diseases, a well-established healthcare system, and the presence of major medical device manufacturers in the region. The market in North America is projected to grow at a CAGR of 8.2%, reflecting the ongoing trends toward advanced minimally invasive surgical techniques and the rising demand for endovascular interventions.

In Europe, the stent grafts market is experiencing steady growth, primarily driven by an aging population and increasing awareness of advanced vascular treatments. The market is expected to reach USD 1.5 billion by 2030, with a CAGR of 7.8% during the forecast period. The Asia Pacific region is also emerging as a significant market for stent grafts, fueled by expanding healthcare infrastructure and rising disposable incomes. The increasing prevalence of lifestyle diseases in countries such as China and India is anticipated to drive demand, with the market projected to grow at a CAGR of 9.5% in this region. Latin America and the Middle East & Africa are expected to witness slower growth rates but remain important markets due to increasing healthcare investments and the rising burden of chronic diseases.

Opportunities

The stent grafts market is ripe with opportunities, particularly in emerging economies where healthcare access is expanding. As nations develop their healthcare infrastructure and adopt advanced medical technologies, the demand for stent grafts is anticipated to rise significantly. Moreover, the growing emphasis on preventive healthcare and early diagnosis is likely to result in increased screening for vascular diseases, subsequently driving the requirement for stent grafts. Manufacturers who strategically position themselves in these burgeoning markets and tailor their product offerings to meet local needs can capitalize on the growing demand and establish a foothold in these regions.

Additionally, the potential for innovation in stent graft technology presents an exciting opportunity for market players. New materials, such as biodegradable stents and those imbued with drug-eluting capabilities, can significantly enhance treatment outcomes and patient safety. Research and development efforts focusing on creating customized stent designs for specific patient anatomies are likely to yield new products that can better address the unique challenges of vascular diseases. Companies that invest in R&D and collaborate with healthcare providers to understand their requirements can drive the next wave of innovation in the stent grafts market.

Threats

Despite the significant growth prospects, the stent grafts market faces several threats that could impede its expansion. One of the primary threats is the increasing competition among manufacturers, leading to price wars that could reduce profit margins. As more players enter the market, particularly in developing regions, companies must differentiate their products and focus on building brand loyalty to maintain their market position. Additionally, stringent regulatory requirements and the lengthy approval processes for new medical devices can pose challenges for manufacturers seeking to introduce innovative stent grafts. Delays in product approvals can hinder market entry and limit growth opportunities.

Another significant threat is the potential for adverse events associated with stent grafts, such as thrombosis, stent migration, or infection. These complications can lead to patient dissatisfaction and may result in legal liabilities for manufacturers. Furthermore, negative publicity stemming from such events can erode consumer confidence in stent graft products and impact sales. Continuous monitoring of product performance and implementing rigorous quality control measures are crucial for mitigating these threats and ensuring the long-term success of stent grafts in the market.

Competitor Outlook

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Cook Medical
• Terumo Corporation
• Johnson & Johnson
• Gore Medical
• Cardinal Health, Inc.
• MicroPort Scientific Corporation
• Biotronik SE & Co. KG
• Endologix, Inc.
• Merit Medical Systems, Inc.
• Medtronic Vascular
• Stryker Corporation
• Philips Healthcare

The competitive landscape of the stent grafts market is characterized by the presence of established players and several emerging companies striving for a share of this growing industry. Major companies such as Medtronic and Boston Scientific are at the forefront, continuously innovating their product offerings to cater to the diverse needs of healthcare providers and patients. These companies invest heavily in research and development to introduce advanced stent graft technologies, including drug-eluting options and specialized stent designs that address specific vascular conditions. Their strong market position is bolstered by extensive distribution networks and robust customer relationships built over decades of operation.

Emerging players like Endologix and MicroPort Scientific are also making their mark in the stent grafts market by focusing on niche applications and developing innovative products that enhance treatment outcomes. These companies are capitalizing on advancements in technology to create solutions that minimize complications and improve patient recovery. The competitive dynamics in the stent grafts market are further intensified by the increasing focus on patient-centered care, with companies striving to differentiate their offerings based on efficacy, safety, and ease of use.

As the market continues to expand, collaborations and partnerships between established players and innovative startups are becoming common strategies to enhance product offerings and accelerate market entry. Companies that successfully navigate the dynamic landscape, adapt to changing customer needs, and foster innovation will be well-positioned to capture market share in the evolving stent grafts market. Overall, the competitive environment is expected to remain active, with ongoing mergers, acquisitions, and strategic alliances shaping the future of the industry.